Regeneron Pharmaceuticals
REGN
REGN
1,153 hedge funds and large institutions have $66.7B invested in Regeneron Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 169 funds opening new positions, 334 increasing their positions, 462 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,153
Holders Change
+78
Holders Change %
+7.26%
% of All Funds
18.6%
Holding in Top 10
30
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-11.76%
% of All Funds
0.48%
New
169
Increased
334
Reduced
462
Closed
71
Calls
$1.27B
Puts
$1.57B
Net Calls
-$305M
Net Calls Change
+$14.6M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$291M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$252M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$207M |
| 4 |
Goldman Sachs
New York
|
+$94.4M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$71.4M |
Top Sellers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$273M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$233M |
| 3 |
BlackRock
New York
|
-$231M |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$185M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$183M |